What does Cytokinetics, Incorporated do?
Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor…
What is Cytokinetics, Incorporated's P/E and P/B ratio?
Cytokinetics, Incorporated has a P/E ratio of -8.6 and a P/B ratio of -49.95.
What is Cytokinetics, Incorporated's debt-to-equity ratio?
Cytokinetics, Incorporated has a debt-to-equity ratio of -1.95.
How much does Cytokinetics, Incorporated owe compared with what it owns?
Cytokinetics, Incorporated owes $1.09 for every $1 it owns (balance sheet Jun 2026), which means it owes more than it owns.
What is Cytokinetics, Incorporated's Positivity rank?
Cytokinetics, Incorporated is ranked #6,687 of 6,775 companies globally and #3,922 of 4,000 in United States on PositoAI, with a Positivity Score of -46,436.
Does Cytokinetics, Incorporated have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Cytokinetics, Incorporated.
Where can I read the latest news about Cytokinetics, Incorporated?
Recent headlines about Cytokinetics, Incorporated from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Cytokinetics, Incorporated have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Cytokinetics, Incorporated's current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.